Stockreport

Eli Lilly investors shouldn't sweat rival Novo Nordisk having the first obesity pill on sale [CNBC]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Brendan McDermid | Reuters Jim Cramer says don't sweat Novo Nordisk's head start over Club holding Eli Lilly in the obesity pill market. [Read more]